AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

958.705

-4.230-0.44%

Number of Gainers:9

Number of Losers:12

Number of Flat:11

PE:- -

High:966.173

Open:965.729

Low:958.143

Close:962.935

Volume:25.37M

Turnover:331.09M

Market Cap:251.02B

Float Cap:194.79B

Loading ...

IGA takes on Woolies and Coles with new rewards program

The West Australian

Lark's CEO Change Surprising But Strong Replacement Chosen -- Market Talk

Five Point Prices $450 Million Debt Offering

MT Newswires Live

BRIEF-CSL Partners On New Coagulation Treatment

CSL Partners with VarmX to Develop New Treatment for FXa Inhibitor Bleeding

MT Newswires Live

CSL Ltd - Varmx Will Receive Payments of up to US$388 Mln up to Launch of Vmx-C001, Plus Further Commercial Milestones Thereafter

THOMSON REUTERS

CSL Ltd - Entered Into an Agreement With Privately Held Dutch Biotech Company, Varmx BV

THOMSON REUTERS

CSL Ltd - Will Make an Upfront Payment to Varmx of US$117 Mln for an Exclusive Option to Acquire Company

THOMSON REUTERS

CSL Ltd - Agreement to Develop a New Treatment to Restore Blood Coagulation in Patients Taking a Fxa Inhibitor

THOMSON REUTERS

Will Mumford’s go to metric for finding high-quality stocks

Corruption Probe and Governance Risks Could Be a Game Changer for IDT (IDT)

Simply Wall St.

Mesoblast (ASX:MSB) Valuation in Focus After Ryoncil Launch and Pipeline Milestones Unveiled in New York

Simply Wall St.

OMG Group Increases Range of PrOATein RTD Products Available in Woolworths Stores Nationwide

Lark Distilling Appoints CEO

MT Newswires Live

BRIEF-Lark Distilling Appoints Stuart Gregor As CEO Effective Jan 2026

Coles' Price Perception Likely to Drive Share Gains -- Market Talk

Lark Distilling Co Ltd - Stuart Gregor to Succeed Satya Sharma as CEO

THOMSON REUTERS

Lark Distilling Co Ltd - Appoints Stuart Gregor as CEO Effective Jan 2026

THOMSON REUTERS

Innovation or illusion? How to spot the real disruptors (and 4 ASX ideas for your trouble)

ASX opportunities after earnings season

Morning Star AU

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7501/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":958.70496,"timestamp":1758174592518,"preClose":962.9346,"halted":0,"volume":25372799,"delay":0,"changeRate":-0.004392,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-4.229614,"latestTime":"09-18 15:49:52 AEST","open":965.729,"high":966.17346,"low":958.14343,"amount":331087204,"amplitude":0.008339,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1758175200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1758153600000,1758175200000]],"turnoverRate":0.00177,"increases":9,"decrements":13,"flats":11,"marketCap":251017228173,"floatMarketCap":194790260160.89844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":966.17346,"amplitude":0.008339,"preClose":962.9346,"low":958.14343,"latestPrice":958.70496,"volume":25372799,"delay":0,"open":965.729,"prevYearClose":1117.913,"prevWeekClose":985.392,"prevMonthClose":1001.199,"prevQuarterClose":1033.641,"fiveDayClose":978.647,"twentyDayClose":1046.626,"sixtyDayClose":1035.612,"secType":"PLATE","market":"AU","turnoverRate":0.00177,"marketCap":251017228173,"floatMarketCap":194790260160.89844,"timestamp":1758174592518,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":9,"down":12,"flat":11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568091443","title":"IGA takes on Woolies and Coles with new rewards program","url":"https://stock-news.laohu8.com/highlight/detail?id=2568091443","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568091443?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:03","pubTimestamp":1758110585,"startTime":"0","endTime":"0","summary":"Supermarket giant IGA has launched a new rewards program as it looks to take on the duopoloy of Woolworths and Coles.","market":"nz","thumbnail":"https://images.thewest.com.au/publication/C-20056073/4274779e42f70f3ca9843e817ebd5043c9a9505f.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20056073/4274779e42f70f3ca9843e817ebd5043c9a9505f.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/retail/iga-in-fresh-bid-to-take-on-woolies-and-coles-as-new-rewards-program-launched-c-20056073","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/retail/iga-in-fresh-bid-to-take-on-woolies-and-coles-as-new-rewards-program-launched-c-20056073","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK7511","BK7501","BK7082","BK7040","COL.AU","WOW.AU"],"gpt_icon":0},{"id":"2568431437","title":"Lark's CEO Change Surprising But Strong Replacement Chosen -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2568431437","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568431437?lang=en_us&edition=fundamental","pubTime":"2025-09-17 06:40","pubTimestamp":1758062400,"startTime":"0","endTime":"0","summary":"2230 GMT [Dow Jones]--Lark Distilling's CEO change surprises bull Canaccord Genuity. Lark said Sash Sharma would step down as CEO at the end of December, to be replaced by Stuart Gregor, co-founder of Four Pillars Gin and a current nonexecutive director on Lark's board. Analyst Allan Franklin considers Gregor to be a strong successor, noting his experience in growing Four Pillars to the point that it was acquired by Kirin Holdings unit Lion in 2023. \"Executing on the sales acceleration both domestically and internationally remains the key watch point for investors,\" says Canaccord. It expects sales to pick up from 2Q of FY 2026. Canaccord retains a buy call and A$1.34/share price target on Lark, which ended Tuesday at A$0.81. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lark's CEO Change Surprising But Strong Replacement Chosen -- Market Talk","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7097","LRK.AU"],"gpt_icon":0},{"id":"2567817279","title":"Five Point Prices $450 Million Debt Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2567817279","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567817279?lang=en_us&edition=fundamental","pubTime":"2025-09-16 15:47","pubTimestamp":1758008835,"startTime":"0","endTime":"0","summary":"Five Point Holdings  said late Monday its Five Point Operating and Five Point Capital subsidiaries have priced $450 million worth of 8% senior notes due 2030.The notes will be issued at par and the issuance is expected to close Sept. 25.The net proceeds from the offering, together with cash on hand, will be used to redeem other debt, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","FPH.AU","BK4193","BK7007","FPH"],"gpt_icon":0},{"id":"2567243121","title":"BRIEF-CSL Partners On New Coagulation Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2567243121","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567243121?lang=en_us&edition=fundamental","pubTime":"2025-09-16 09:19","pubTimestamp":1757985568,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Partners On New Coagulation TreatmentSept 16  - CSL Ltd CSL.AX:CSL PARTNERS ON NEW COAGULATION TREATMENTENTERED INTO AN AGREEMENT WITH PRIVATELY HELD DUTCH BIOTECH COMPANY, VARMX BVAGREEMENT TO DEVELOP A NEW TREATMENT TO RESTORE BLOOD COAGULATION IN PATIENTS TAKING A FXA INHIBITORWILL MAKE AN UPFRONT PAYMENT TO VARMX OF US$117 MILLION FOR AN EXCLUSIVE OPTION TO ACQUIRE COMPANYVARMX WILL RECEIVE PAYMENTS OF UP TO US$388 MILLION UP TO LAUNCH OF VMX-C001, PLUS FURTHER COMMERCIAL MILESTONES THEREAFTERFurther company coverage: CSL.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250916:nFWN3V2176:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7501","BK7511","BK7508"],"gpt_icon":0},{"id":"2567412560","title":"CSL Partners with VarmX to Develop New Treatment for FXa Inhibitor Bleeding","url":"https://stock-news.laohu8.com/highlight/detail?id=2567412560","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567412560?lang=en_us&edition=fundamental","pubTime":"2025-09-16 07:36","pubTimestamp":1757979393,"startTime":"0","endTime":"0","summary":"CSL  has partnered with VarmX to develop VMX-C001, a recombinant factor X protein to restore blood clotting in patients on Factor Xa inhibitors facing severe bleeding or requiring urgent surgery, according to a Tuesday Australian bourse filing.The FXa inhibitor is used by more than 20 million patients globally for chronic anticoagulation therapy, with around 3% experiencing severe bleeding or requiring urgent surgery, the filing said.The company will finance VarmX's global phase 3 trial and provide support for late-stage development, manufacturing, and pre-launch activities, per the filing.The company will make an upfront payment of $117 million to VarmX for an exclusive option to acquire the company following phase 3 results, with potential additional payments of up to $388 million plus commercial milestones.The treatment is slated for a commercial launch in 2029, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169590202.USD","LU0728928796.USD","BK7511","LU1169589451.USD","CSL.AU","BK4086","BK7508","CSL","SGXZ23171101.USD","BK7501","BK7067","SG9999004303.SGD"],"gpt_icon":0},{"id":"2567908128","title":"CSL Ltd - Varmx Will Receive Payments of up to US$388 Mln up to Launch of Vmx-C001, Plus Further Commercial Milestones Thereafter","url":"https://stock-news.laohu8.com/highlight/detail?id=2567908128","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567908128?lang=en_us&edition=fundamental","pubTime":"2025-09-16 06:01","pubTimestamp":1757973714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nFWN3V2176:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7511","BK7501","CSL.AU"],"gpt_icon":0},{"id":"2567289091","title":"CSL Ltd - Entered Into an Agreement With Privately Held Dutch Biotech Company, Varmx BV","url":"https://stock-news.laohu8.com/highlight/detail?id=2567289091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567289091?lang=en_us&edition=fundamental","pubTime":"2025-09-16 06:01","pubTimestamp":1757973714,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nFWN3V2176:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7501","BK7508","BK7067","BK7511"],"gpt_icon":0},{"id":"2567128906","title":"CSL Ltd - Will Make an Upfront Payment to Varmx of US$117 Mln for an Exclusive Option to Acquire Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2567128906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567128906?lang=en_us&edition=fundamental","pubTime":"2025-09-16 06:01","pubTimestamp":1757973714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nFWN3V2176:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","CSL.AU","BK7508","BK7501","BK7067"],"gpt_icon":0},{"id":"2567128905","title":"CSL Ltd - Agreement to Develop a New Treatment to Restore Blood Coagulation in Patients Taking a Fxa Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2567128905","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567128905?lang=en_us&edition=fundamental","pubTime":"2025-09-16 06:01","pubTimestamp":1757973714,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nFWN3V2176:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7511","BK7501","BK7067","BK7508"],"gpt_icon":0},{"id":"2567014207","title":"Will Mumford’s go to metric for finding high-quality stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2567014207","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567014207?lang=en_us&edition=fundamental","pubTime":"2025-09-16 04:00","pubTimestamp":1757966413,"startTime":"0","endTime":"0","summary":"What’s the first thing you look at to figure out if a company is high-quality?Return-on-equity, margins or perhaps its a qualitative factor like customer retention.Will Mumford, Deputy Portfolio Manager at Auscap Asset Management, says he looks for long-term earnings growth as the best litmus test for identifying quality.Will Mumford: I’d say neutral overall. The market’s P/E multiple is historically high - that’s clear. But within the market there’s a lot of variability. Some sectors are cheap, and interestingly, those aren’t necessarily the lower-quality areas. That creates opportunities.Will Mumford:I’d call out Eagers Automotive . Every time we meet with them, they’ve got a new initiative that could be a game changer. Not everything works — for example, the plan to consolidate dealerships at Brisbane Airport fell through. But their joint venture with B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/will-mumford-s-go-to-metric-for-finding-high-quality-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/will-mumford-s-go-to-metric-for-finding-high-quality-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["RMD.AU","BK7007","BK7501","APE.AU","BK7143"],"gpt_icon":0},{"id":"2567141622","title":"Corruption Probe and Governance Risks Could Be a Game Changer for IDT (IDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567141622","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567141622?lang=en_us&edition=fundamental","pubTime":"2025-09-15 21:56","pubTimestamp":1757944578,"startTime":"0","endTime":"0","summary":"In recent days, the Independent Development Trust (IDT) has come under renewed scrutiny following allegations of corruption involving suspended CEO Tebogo Malaka, including accusations of attempted bribery of a journalist and procurement irregularities linked to an R800 million oxygen plant project. \nThis high-profile probe has triggered criticism of political interference and prompted the appointment of PwC to conduct an independent investigation, highlighting concerns around governance and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice1-main-header/1585186680387","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice1-main-header/1585186680387"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/telecom/nyse-idt/idt/news/corruption-probe-and-governance-risks-could-be-a-game-change","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/telecom/nyse-idt/idt/news/corruption-probe-and-governance-risks-could-be-a-game-change","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IDT.AU","BK7501","IDT","BK4115","BK7096"],"gpt_icon":0},{"id":"2567514592","title":"Mesoblast (ASX:MSB) Valuation in Focus After Ryoncil Launch and Pipeline Milestones Unveiled in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2567514592","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567514592?lang=en_us&edition=fundamental","pubTime":"2025-09-15 21:56","pubTimestamp":1757944563,"startTime":"0","endTime":"0","summary":"If you are tracking Mesoblast (ASX:MSB), the company’s latest updates at major healthcare conferences in New York are tough to ignore. Mesoblast grabbed attention with news of a strong first quarter launch for Ryoncil, its FDA-approved therapy for pediatric steroid-refractory acute graft versus host disease (SR-aGvHD). In addition to highlighting early sales and new treatment sites coming online, management revealed plans to expand Ryoncil into additional indications, including adult SR-aGvHD...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-in-focus-after-ryoncil-launch-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-in-focus-after-ryoncil-launch-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK7067","MESO","MSB.AU","MSB","BK7501","BK4006","BK7508"],"gpt_icon":0},{"id":"2567198557","title":"OMG Group Increases Range of PrOATein RTD Products Available in Woolworths Stores Nationwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2567198557","media":"Small Caps","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567198557?lang=en_us&edition=fundamental","pubTime":"2025-09-15 13:13","pubTimestamp":1757913213,"startTime":"0","endTime":"0","summary":"OMG Group  has secured a deal with Woolworths Group  to increase the exposure and sales of its Oat Milk Goodness  PrOATein ready-to-drink  products.The company will stock its chocolate- and coffee-flavoured PrOATein drinks on the shelves of 943 supermarkets nationally from November.896 stores  will now stock the chocolate variety, while 873 stores  will offer the coffee option.The expansion more than doubles OMG’s distribution points in Woolworths on a per stock unit  basis, highlighting strong consumer demand for the high-protein functional beverages and reinforcing OMG’s market position as a leading brand in the ‘Better for You’ fast-moving consumer goods category.It complements the ranging of OMG’s 1 Litre Barista Oat Milk product in 900 Woolworths store nationwide, up from an original 544 stores.“The increase in ranging of our high-protein solution to nearly 1,000 stores increases our ability to reach health-conscious consumers and demonstrates Woolworths’ confidence in our brand a","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/OMG-ASX-PrOATein-RTD-Products-Available-Woolworths-Stores-Nationwide.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/OMG-ASX-PrOATein-RTD-Products-Available-Woolworths-Stores-Nationwide.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/omg-group-increases-range-proatein-rtd-products-available-woolworths-stores-nationwide/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/omg-group-increases-range-proatein-rtd-products-available-woolworths-stores-nationwide/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7501","BK7141","WOW.AU","BK7040","BK7511","OMG.AU"],"gpt_icon":0},{"id":"2567928381","title":"Lark Distilling Appoints CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2567928381","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567928381?lang=en_us&edition=fundamental","pubTime":"2025-09-15 12:36","pubTimestamp":1757910973,"startTime":"0","endTime":"0","summary":"Lark Distilling (ASX:LRK) appointed Stuart Gregor as chief executive, effective Jan. 1, 2026, according to a Monday filing with the Australian bourse.Gregor will succeed Satya Sharma, who will step down as CEO on Dec. 31, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LRK.AU","BK7501","BK7097","XJO.AU","XKO.AU","XAO.AU"],"gpt_icon":0},{"id":"2567161956","title":"BRIEF-Lark Distilling Appoints Stuart Gregor As CEO Effective Jan 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2567161956","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567161956?lang=en_us&edition=fundamental","pubTime":"2025-09-15 09:54","pubTimestamp":1757901262,"startTime":"0","endTime":"0","summary":"BRIEF-Lark Distilling Appoints Stuart Gregor As CEO Effective Jan 2026Sept 15 (Reuters) - Lark Distilling LRK.AX:APPOINTS STUART GREGOR AS CEO EFFECTIVE JAN 2026STUART GREGOR TO SUCCEED SATYA SHARMA AS CEOFurther company coverage: LRK.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nFWN3UZ087:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7097","LRK.AU","BK7501"],"gpt_icon":0},{"id":"2567116300","title":"Coles' Price Perception Likely to Drive Share Gains -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2567116300","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567116300?lang=en_us&edition=fundamental","pubTime":"2025-09-15 07:54","pubTimestamp":1757894040,"startTime":"0","endTime":"0","summary":"2354 GMT - Consumers' perception that Coles offers lower prices than Australian grocery rival Woolworths is likely to drive further market-share gains, Citi analysts write in a note. A Citi survey of 1,800 shoppers is seen by the analysts as evidence that Woolworths has more work ahead to convince Australian consumers that they are competitive on pricing. The analysts reckon that the relative success of Coles on this front is helped by the improved online offering facilitated by its new fulfillment centers. While many shoppers signal an intention to shop more at Aldi, Coles is winning relative to Woolworths, the analysts add. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7040","WOW.AU","BK7511","BK7082","COL.AU"],"gpt_icon":0},{"id":"2567716368","title":"Lark Distilling Co Ltd - Stuart Gregor to Succeed Satya Sharma as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2567716368","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567716368?lang=en_us&edition=fundamental","pubTime":"2025-09-15 07:16","pubTimestamp":1757891812,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250914:nFWN3UZ087:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7097","LRK.AU","BK7501"],"gpt_icon":0},{"id":"2567163680","title":"Lark Distilling Co Ltd - Appoints Stuart Gregor as CEO Effective Jan 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2567163680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567163680?lang=en_us&edition=fundamental","pubTime":"2025-09-15 07:16","pubTimestamp":1757891812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250914:nFWN3UZ087:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LRK.AU","BK7501","BK7097"],"gpt_icon":0},{"id":"2567150249","title":"Innovation or illusion? How to spot the real disruptors (and 4 ASX ideas for your trouble)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567150249","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567150249?lang=en_us&edition=fundamental","pubTime":"2025-09-15 04:00","pubTimestamp":1757880037,"startTime":"0","endTime":"0","summary":"We all love a compelling growth story, but how do you tell whether you're buying substance or sizzle?In this episode, we’re diving into one of the most exciting - and sometimes most dangerous - areas of the market: innovation.It’s a word that gets thrown around a lot, but how do you tell the difference between a company with a slick marketing pitch and one that’s genuinely building something transformative?To unpack this, Livewire's Chris Conwayisjoined by Steve Johnson from Forager and Martin Hickson from 1851 Capital.Johnson and Hickson share what innovation means to them, the traits that set true disruptors apart, and the red flags that suggest hype over substance. They also cover how to assess competitive moats, and what metrics matter when profitability hasn't quite yet arrived.Of course, it wouldn't be an episode of Buy Hold Sell without some stock ideas, so the guests each share an ASX innovator that is underrated and the market might be missing, as well as the best innovator ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/innovation-or-illusion-how-to-spot-the-real-disruptors-and-4-asx-ideas-for-your-trouble","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/innovation-or-illusion-how-to-spot-the-real-disruptors-and-4-asx-ideas-for-your-trouble","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["XRO.AU","NAN.AU","BK7126","BK7128","BK7007","BK7501","BK7503","JBH.AU","COH.AU","SKS.AU","DUG.AU","RMD.AU","BK7001","BK7023","BK7016","BBN.AU"],"gpt_icon":0},{"id":"2567109939","title":"ASX opportunities after earnings season","url":"https://stock-news.laohu8.com/highlight/detail?id=2567109939","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567109939?lang=en_us&edition=fundamental","pubTime":"2025-09-15 00:00","pubTimestamp":1757865600,"startTime":"0","endTime":"0","summary":"This reporting season was characterised by a level of volatility we haven’t seen in years. Despite substantial coverage, it wasn’t just Aussie small caps posting wild swings. On average, companies across our coverage universe saw their share prices move over 6% on results days. Big names like CSL and Woolworths had the market pendulum swung against them with mass selloffs – the likes of which we haven’t occurred in decades. Portfolio currently hurting?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-opportunities-after-earnings-season","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-opportunities-after-earnings-season","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["BK7082","COL.AU","WOW.AU","BK7511","BK7501","BK7040"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}]}}